Kristian Bjøro

4.0k total citations
79 papers, 3.0k citations indexed

About

Kristian Bjøro is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kristian Bjøro has authored 79 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hepatology, 36 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Kristian Bjøro's work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (28 papers) and Hepatitis B Virus Studies (13 papers). Kristian Bjøro is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (28 papers) and Hepatitis B Virus Studies (13 papers). Kristian Bjøro collaborates with scholars based in Norway, Denmark and Sweden. Kristian Bjøro's co-authors include Terese Haaland, John Willy Haukeland, Zbigniew Konopski, Else Marit Løberg, Kåre I. Birkeland, Olav Dalgård, Kjell B. Hellum, Kjell Skaug, S. Stray‐Pedersen and Stig S. Frøland and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Hepatology.

In The Last Decade

Kristian Bjøro

77 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristian Bjøro Norway 27 1.9k 1.6k 592 429 290 79 3.0k
Edmondo Falleti Italy 31 1.5k 0.8× 1.1k 0.7× 327 0.6× 461 1.1× 233 0.8× 94 3.0k
Julie R. Jonsson Australia 28 2.6k 1.3× 2.1k 1.3× 658 1.1× 564 1.3× 432 1.5× 54 3.9k
Manuel Hernández‐Guerra Spain 24 1.4k 0.7× 1.2k 0.7× 790 1.3× 308 0.7× 248 0.9× 102 2.6k
Oreste Lo Iacono Italy 27 2.1k 1.1× 1.5k 0.9× 470 0.8× 256 0.6× 291 1.0× 60 2.6k
Massimo Zuin Italy 39 2.3k 1.2× 2.5k 1.5× 1.2k 2.1× 159 0.4× 309 1.1× 142 4.2k
A. Scott Mills United States 27 2.1k 1.1× 1.7k 1.0× 567 1.0× 568 1.3× 412 1.4× 43 3.2k
Wah‐Kheong Chan Malaysia 30 2.8k 1.4× 1.4k 0.9× 768 1.3× 1.1k 2.5× 347 1.2× 112 3.7k
Toshihiko Mizuta Japan 33 2.1k 1.1× 1.4k 0.9× 538 0.9× 733 1.7× 867 3.0× 108 3.9k
Conrado Fernández‐Rodríguez Spain 25 1.5k 0.8× 1.5k 1.0× 476 0.8× 242 0.6× 346 1.2× 93 2.5k
Daniela Cabibi Italy 35 2.6k 1.4× 1.5k 0.9× 677 1.1× 804 1.9× 523 1.8× 160 4.2k

Countries citing papers authored by Kristian Bjøro

Since Specialization
Citations

This map shows the geographic impact of Kristian Bjøro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristian Bjøro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristian Bjøro more than expected).

Fields of papers citing papers by Kristian Bjøro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristian Bjøro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristian Bjøro. The network helps show where Kristian Bjøro may publish in the future.

Co-authorship network of co-authors of Kristian Bjøro

This figure shows the co-authorship network connecting the top 25 collaborators of Kristian Bjøro. A scholar is included among the top collaborators of Kristian Bjøro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristian Bjøro. Kristian Bjøro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalgård, Olav, Michelle Martinot-Peignoux, Hans Verbaan, et al.. (2015). The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection. PLoS ONE. 10(8). e0120866–e0120866. 2 indexed citations
2.
Bjøro, Kristian, et al.. (2014). Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway—A population-based cohort study. Cancer Epidemiology. 38(6). 741–747. 11 indexed citations
3.
Moghaddam, Amir, Espen Melum, Nils Reinton, et al.. (2011). IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. Research at the University of Copenhagen (University of Copenhagen). 6 indexed citations
4.
Dalgård, Olav, Amir Moghaddam, Hans Verbaan, et al.. (2010). Il28B Genetic Variation And Treatment Response In Patients With Hcv Genotype 3 Infection. Hepatology. 52(4). 898–898. 4 indexed citations
5.
Yndestad, Arne, John Willy Haukeland, Tuva B. Dahl, et al.. (2009). A Complex Role of Activin A in Non-Alcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 104(9). 2196–2205. 64 indexed citations
6.
Haukeland, John Willy, Zbigniew Konopski, Heidi B. Eggesbø, et al.. (2009). Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scandinavian Journal of Gastroenterology. 44(7). 853–860. 263 indexed citations
7.
Dalgård, Olav, Hans Verbaan, Helmer Ring‐Larsen, & Kristian Bjøro. (2008). IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS. Hepatology. 48(4). 1875–1875. 2 indexed citations
8.
Melum, Espen, Styrbjörn Friman, Kristian Bjøro, et al.. (2007). Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma. Journal of Hepatology. 47(6). 777–783. 24 indexed citations
9.
Andriulli, Angelo, Olav Dalgård, Kristian Bjøro, & Alessandra Mangia. (2006). Short-term treatment duration for HCV-2 and HCV-3 infected patients. Digestive and Liver Disease. 38(10). 741–748. 24 indexed citations
10.
Haukeland, John Willy, Zbigniew Konopski, Else Marit Løberg, et al.. (2005). Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology. 40(12). 1469–1477. 70 indexed citations
11.
Dalgård, Olav, Kristian Bjøro, Kjell B. Hellum, et al.. (2004). Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot Study. Hepatology. 40(6). 1260–1265. 240 indexed citations
12.
Isoniemi, Helena, Ulrika Broomé, Michael Olausson, et al.. (2004). Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. Journal of Hepatology. 40(5). 815–822. 135 indexed citations
13.
Bell, Helge, Olav Dalgård, Kristian Bjøro, Kjell B. Hellum, & Bjørn Myrvang. (2002). Behandling ved kronisk hepatitt C. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
14.
Bjøro, Kristian, Preben Olund Kirkegaard, Bo‐Göran Ericzon, et al.. (2001). Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?. Transplantation Proceedings. 33(4). 2511–2513. 4 indexed citations
15.
Bjøro, Kristian, Henrik Krarup, H. Bell, et al.. (1995). Two Dose Regimens of Recombinant Interferon-Alpha-2b in Chronic Hepatitis C Virus Infection: Biochemistry, Hepatitis C Virus RNA, and Liver Histology as Response Indices. Scandinavian Journal of Gastroenterology. 30(11). 1119–1124. 10 indexed citations
16.
Bjøro, Kristian, et al.. (1995). Monstrous Ascites in Hereditary Haemorrhagic Telangiectasia. Scandinavian Journal of Gastroenterology. 30(1). 92–94. 10 indexed citations
17.
Rollag, Halvor, et al.. (1993). [Hepatitis C virus infections among persons attending special clinics dealing with problems related to social conditions].. PubMed. 113(19). 2397–400. 1 indexed citations
18.
Blaabjerg, Ole, et al.. (1990). The Nordic Protein Project. Upsala Journal of Medical Sciences. 95(3). 251–255. 10 indexed citations
19.
Haugen, Guttorm, S. Stray‐Pedersen, & Kristian Bjøro. (1990). Prostanoid production in umbilical arteries from preterm and term deliveries perfused in vitro. Early Human Development. 24(2). 153–161. 6 indexed citations
20.
Haugen, Guttorm, S. Stray‐Pedersen, & Kristian Bjøro. (1990). Vasoactive Intestinal Peptide and Prostanoid Production in Normal and Single Umbilical Artery Cords in Normotensive and Hypertensive Pregnancies. Hypertension in Pregnancy. 9(1). 69–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edmondo Falleti Breakdown of academic impact, for papers by Julie R. Jonsson Breakdown of academic impact, for papers by Manuel Hernández‐Guerra Breakdown of academic impact, for papers by Oreste Lo Iacono Breakdown of academic impact, for papers by Massimo Zuin Breakdown of academic impact, for papers by A. Scott Mills Breakdown of academic impact, for papers by Wah‐Kheong Chan Breakdown of academic impact, for papers by Toshihiko Mizuta Breakdown of academic impact, for papers by Conrado Fernández‐Rodríguez Breakdown of academic impact, for papers by Daniela Cabibi
Rankless by CCL
2026